Suscribirse

Reduced occurrence of early atopic dermatitis because of immunoactive prebiotics among low-atopy-risk infants - 07/08/11

Doi : 10.1016/j.jaci.2010.07.022 
Christoph Grüber, MD, PhD a, b, , Margriet van Stuijvenberg, MD, MPH c, Fabio Mosca, MD, PhD, NICU d, e, Guido Moro, MD, PhD f, Gaetano Chirico, MD, PhD g, Christian P. Braegger, MD h, Josef Riedler, MD, PhD i, Günther Boehm, MD, PhD j, Ulrich Wahn, MD, PhD a

MIPS 1 Working Group

a Department of Pediatric Pneumology and Immunology, Charité-Universitätsmedizin Berlin, Berlin, Germany 
b Department of Pediatrics, Klinikum Frankfurt (Oder), Frankfurt (Oder), Germany 
c Division of Neonatology, Beatrix Children’s Hospital, UMC Groningen, Groningen, The Netherlands 
d Fondazione IRCCS “Ca’Granda” Ospedale Maggiore, Milan, Italy 
e Policlinico, University Department of Mother and Infant Sciences, University of Milan, Milan, Italy 
f Macedonio Melloni Hospital, Milan, Italy 
g Department of Neonatology, Spedali Civili, Brescia, Italy 
h Division of Paediatric Gastroenterology and Nutrition, University Children’s Hospital, Zürich, Switzerland 
i Children’s Hospital, Schwarzach Hospital, Schwarzach, Austria 
j Danone Research Center for Specialized Nutrition, Friedrichsdorf, Germany 

Reprint requests: Christoph Grüber, MD, PhD, Department of Pediatrics, Klinikum Frankfurt (Oder) GmbH, PO Box 1281, D-15202 Frankfurt (Oder), Germany.

Abstract

Background

Most infants developing atopic dermatitis have a low risk for atopy. Primary prevention of atopic dermatitis is difficult.

Objective

To assess the effect of supplementation of an infant and follow-on formula with prebiotic and immunoactive oligosaccharides on the occurrence of atopic dermatitis in the first year of life.

Methods

Healthy term infants from 5 European countries with low atopy risk were recruited before the age of 8 weeks, either having started with formula feeding or being on full breast-feeding (breast-feeding group). Formula-fed infants were randomized to feeding with a regular formula containing a specific mixture of neutral oligosaccharides and pectin-derived acidic oligosaccharides (prebiotic formula group) or regular formula without oligosaccharides (control formula group).

Results

A total of 414 infants were randomized to the prebiotic group and 416 infants to the control group. A total of 300 infants were followed in the breast-feeding group. Up to the first birthday, atopic dermatitis occurred in significantly fewer infants from the prebiotic group (5.7%) than from the control group (9.7%; P = .04). The cumulative incidence of atopic dermatitis in the prebiotic group was in the low range of the breast-feeding group (7.3%). In a Cox regression model, the rate of atopic dermatitis was significantly lower by 44% in the prebiotic group versus the control group (P = .04). The number needed to prevent 1 case of atopic dermatitis by supplementation of prebiotics was 25 infants.

Conclusion

Formula supplementation with a specific mixture of oligosaccharides was effective as primary prevention of atopic dermatitis in low atopy risk infants.

El texto completo de este artículo está disponible en PDF.

Key words : Oligosaccharides, atopic dermatitis, infant, primary prevention, prebiotics

Abbreviations used : AD, BG, CG, lcFOS, pAOS, PG, scGOS, SCORAD, TARC


Esquema


 Supported by Danone Research, Friedrichsdorf, Germany. The role of the funder has been to supply the study formulas and facilitate the data collection and data analysis.
 Disclosure of potential conflict of interest: C. Grüber receives honoraria from Danone. F. Mosca receives research support from Danone/Numico. C. P. Braegger has consultant arrangements and receives research support from Danone. J. Riedler is on the advisory board for Numico and receives research support from MIPS. U. Wahn receives research support from Danone. The rest of the authors have declared that they have no conflict of interest.


© 2010  American Academy of Allergy, Asthma & Immunology. Publicado por Elsevier Masson SAS. Todos los derechos reservados.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 126 - N° 4

P. 791-797 - octobre 2010 Regresar al número
Artículo precedente Artículo precedente
  • The prostaglandin D2 receptor CRTH2 is important for allergic skin inflammation after epicutaneous antigen challenge
  • Rui He, Michiko K. Oyoshi, James Y.T. Wang, Martin R. Hodge, Haoli Jin, Raif S. Geha
| Artículo siguiente Artículo siguiente
  • National prevalence and risk factors for food allergy and relationship to asthma: Results from the National Health and Nutrition Examination Survey 2005-2006
  • Andrew H. Liu, Renee Jaramillo, Scott H. Sicherer, Robert A. Wood, S. Allan Bock, A. Wesley Burks, Mark Massing, Richard D. Cohn, Darryl C. Zeldin

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.

¿Ya suscrito a @@106933@@ revista ?

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2025 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.